|
|
HHSN292201500060U
|
$5,878,180
|
$5,878,180
|
N/A
|
CONSTELLATION NEW ENERGY
|
|
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research
|
5P20CA192988-04
|
$179,686
|
$179,686
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
|
5R01CA208526-02
|
$472,047
|
$472,047
|
CUCINOTTA, FRANCIS
|
UNIVERSITY OF NEVADA LAS VEGAS
|
|
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
|
1R01CA215802-01
|
$503,309
|
$503,309
|
SPARREBOOM, ALEXANDER
|
OHIO STATE UNIVERSITY
|
|
(Diversity supplement to R01CA188096) Targeting autophagaphy in hereditary breast cancer
|
3R01CA188096-03S1
|
$57,707
|
$57,707
|
XIA, BING
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis
|
1R21CA216304-01
|
$234,900
|
$234,900
|
NEWMEYER, DONALD
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
|
1R01CA205965-01A1
|
$650,815
|
$650,815
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ#9) Promoting Axon Stability to Prevent Therapy-induced Peripheral Neuropathy
|
1R01CA219866-01
|
$445,407
|
$445,407
|
DIANTONIO, AARON
|
WASHINGTON UNIVERSITY
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-02
|
$438,499
|
$438,499
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
1R01CA216054-01
|
$324,411
|
$324,411
|
HAYDEN, MELANIE
|
STANFORD UNIVERSITY
|
|
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
|
1R01CA206483-01A1
|
$718,958
|
$718,958
|
EMU, BRINDA
|
YALE UNIVERSITY
|
|
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
|
5R21CA206309-02
|
$182,192
|
$182,192
|
HARRIS, REUBEN
|
UNIVERSITY OF MINNESOTA
|
|
(PQ3) Disruption of immune surveillance by aneuploidy and aberrant MHCII expression
|
1R01CA220009-01
|
$310,000
|
$310,000
|
ZANETTI, MAURIZIO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
1R01CA216265-01
|
$632,860
|
$632,860
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-03S1
|
$57,872
|
$57,872
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-03
|
$334,552
|
$334,552
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
|
1R01CA216242-01
|
$318,277
|
$318,277
|
MACLEOD, KAY
|
UNIVERSITY OF CHICAGO
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
1R01CA217138-01
|
$644,421
|
$644,421
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
5R01CA208642-02
|
$352,275
|
$352,275
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
1R21CA216830-01
|
$231,000
|
$231,000
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
|
5R01CA206012-02
|
$402,548
|
$402,548
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
|
5R01CA205975-02
|
$386,619
|
$386,619
|
GHAFFARI, SAGHI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis
|
5R21CA206352-02
|
$198,125
|
$198,125
|
PALEFSKY, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ5) Role of Mitochondrial Division in Cancer Biology
|
5R01CA206005-02
|
$351,209
|
$351,209
|
CHIPUK, JERRY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
|
5R01CA185293-04
|
$329,104
|
$329,104
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
|
5R01CA179992-04
|
$909,181
|
$909,181
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
5R01CA185062-04
|
$312,304
|
$312,304
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
|
5R01CA185020-04
|
$325,181
|
$325,181
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-03
|
$446,627
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-04
|
$517,690
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
5R01CA185137-04
|
$882,372
|
$882,372
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-03
|
$553,740
|
$553,740
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQC2)Nanoscale changes in 3D nuclear architecture during breast tumorigenesis
|
5R01CA185363-04
|
$318,250
|
$318,250
|
LIU, YANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQC6) Molecular Determinants of Quiescent Cancer Cells
|
5R01CA185086-04
|
$423,327
|
$423,327
|
VASUDEVAN, SHOBHA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
|
5R01CA185509-04
|
$258,128
|
$258,128
|
GHOSH, PARAMITA
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
(PQD1) An Iterative Approach for Overcoming Evolving Targeted Therapy Resistance
|
5R01CA185404-04
|
$328,888
|
$328,888
|
WU, LANI
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQD1) Clonal heterogeneity and targeted therapy resistance in melanoma
|
5R01CA185072-04
|
$348,312
|
$348,312
|
SEKULIC, ALEKSANDAR
|
MAYO CLINIC ARIZONA
|
|
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
|
5R01CA184320-04
|
$738,276
|
$738,276
|
SARKARIA, JANN
|
MAYO CLINIC ROCHESTER
|
|
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care
|
5R01CA190016-04
|
$617,350
|
$617,350
|
NATTINGER, ANN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048377-24
|
$39,000
|
$39,000
|
GADDE, KISHORE
|
LSU PENNINGTON BIOMEDICAL RESEARCH CTR
|
|
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048381-24
|
$68,181
|
$68,181
|
EHRMANN, DAVID
|
UNIVERSITY OF CHICAGO
|
|
03/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048468-24
|
$68,181
|
$68,181
|
Furlong, Kevin
|
THOMAS JEFFERSON UNIVERSITY
|
|
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048434-24
|
$68,181
|
$68,181
|
Goldberg, Ronald
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
05/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Proj
|
U01DK048514-24
|
$68,181
|
$68,181
|
HAZUDA, HELEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048375-24
|
$68,181
|
$68,181
|
Dabelea, Dana
|
UNIVERSITY OF COLORADO DENVER
|
|
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 Research Project
|
U01DK048437-24
|
$42,300
|
$42,300
|
Horton, Edward
|
JOSLIN DIABETES CENTER
|
|
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048413-24
|
$68,181
|
$68,181
|
Kahn, Steven
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
|
09/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048411-24
|
$37,181
|
$37,181
|
DAGOGO-JACK, SAMUEL
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
1 BASE PERIOD: HDRP MEETING AND WORK GROUP SUPPORT $27,711.89
|
261201400011I
|
$1,353,862
|
$1,353,862
|
UNKNOWN, UNKNOWN
|
SCIENTIFIC CONSULTING GRO
|
|
1/2 Howard/Hopkins Intercenter Collaboration in HPV-Associated Cancer Studies
|
5P20CA192989-04
|
$183,470
|
$183,470
|
PANG, XIAOWU
|
HOWARD UNIVERSITY
|
Total relevant funding to Cancer for this search: $2,517,669,527
|